Table: begin end state 1 11 non-cytoplasmic 12 40 transmembrane 41 51 cytoplasmic 52 74 transmembrane 75 97 non-cytoplasmic 98 120 transmembrane 121 139 cytoplasmic 140 165 transmembrane 166 173 non-cytoplasmic 174 196 transmembrane 197 235 cytoplasmic 236 254 transmembrane 255 259 non-cytoplasmic 260 279 transmembrane 280 296 cytoplasmic 297 317 transmembrane 318 332 non-cytoplasmic 333 359 transmembrane 360 370 cytoplasmic 371 390 transmembrane 391 419 non-cytoplasmic 420 442 transmembrane 443 449 cytoplasmic
Input: >HSERO_RS13470 MSPLTLGVLYGVVTIVVMCSGMPIAFALGVVATGFMYFFMPESSLDTITQNVYEEIASIT LLSIPLFILKGAAIGKSPAGKDLYSAIHAWLNKVPGGLGIANVFACALFAAMAGSSPATC SAIGSAGIPEMRRRGYSPGFAAGIIAAGGTLGILLPPSITMILYAVAAEQSLGRLFLAGI GPGVLLVLLFAGYAVYRARKEYRLAHAVYSAGGAKSAYLDDEHFTLAQKVEMLPRVLPFL ILLIGVMVALYGGLATPSETAGLGALLALVLIAVVYRIYKPREIAPFLSSTIKESGMLLL IIGMSLLYSYVMSYLHISQSAAQWVVDLHLSKWLLLAVILGMVIVLGFFLPPVSIILMTA PIILPPLKAAGFDLIWFGIVMTVVMEMGLIHPPVGLNLFVIKNIAPDIALGDVIKGTIPF LALMFLAVLLLCMFPGIATLLPDLLMGAK
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server